|
|
|
|
|
 |
|
|
|
Yakub - Kremastinos: Shield for the heart: Some oil a day, keeps the cardiologist away? ...!
According to many years of research conducted by Professor of Cardiology, Dimitrios Kremastinos, Associate Professor of Cardiology, Efstathios Iliodromitis, and their colleagues at the Research and Experimental Center of the Greek Pharmaceutical ELPEN the reasonable use of a quantity of oil in the food and salads we consume each day is likely to create a protective shield for our hearts.
According to the research results (presented by Professor Magknti Yacoub), the ingredient oleuropein has beneficial properties for the heart. The experimental study in rabbits showed that administration of oleuropein reduces the extent of myocardial infarction in normal rabbits. Moreover, this component protects against oxidative damage during ischemia - epenaimatosis.
Also indicated that the 10 and 20 micrograms oleuropein, reduces total cholesterol by 28.7% and 33% and triglycerides by 41.1% and 61.4% respectively. The quantity of oil to a positive result should be calculated using a spoon per meal, or salad.
The administration of oleuropein has protective and therapeutic effect on cardiotoxicity caused by acute and chronic administration adrianomykinis.
Prof. Kremastinos highlighted the need for research funding in humans to determine the exact dosage evropainis, which must be given to the positive results. The State he said, helps to an extent but more funding should be available from companies that should fund research and not just respond to profitability. "
On his part, Mr. Yacoub, noted that "without research there can be no progress in the world" and referred to a new program developed by ELPEN, in collaboration with scientists at Imperial College London, under Stergios Theodoropoulos, Director of IASO General cardiac clinic.
The ongoing research is performed at an experimental stage in pigs with use of a new implantable device for measuring pressure at different points of the heart, and in other parts of the circulatory system. The device is very compact, simple to use and in future it will also have applications to other institutions and will offer greater capacity measurements. The facility will be wireless and will always give valuable information on the hemodynamic status of heart. Thus, treating physicians will have a clear picture of the problem, so they can intervene effectively to treatment.
According to Mr. Yacoub tests on humans are expected to begin in 2011, when there will be the first clinical results.
On his part Vice ELPEN Theodore Trifon reported on the activities of the company, stressing that the expansion proceeds of Research and Experimental Center of Athens, and in 2011 created corresponding center, and Thessalonica. |
|
|
| |
|
|
|
|
|
|
|
|
|
